Novo Nordisk A/S (NVO)
51.16
-0.31
(-0.60%)
USD |
NYSE |
Dec 30, 16:00
51.15
-0.01
(-0.02%)
After-Hours: 20:00
Novo Nordisk Market Cap: 227.33B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 12.79B |
| Evaxion AS | 30.13M |
| Regeneron Pharmaceuticals, Inc. | 81.40B |
| Omeros Corp. | 1.205B |
| Viking Therapeutics, Inc. | 3.994B |
Market Cap Related Metrics
| PE Ratio | 14.90 |
| PS Ratio | 4.881 |
| PEG Ratio | 1.316 |
| Price to Book Value | 11.21 |
| Price to Free Cash Flow | 24.65 |
| Price | 51.16 |
| Earnings Yield | 6.71% |
| PEGY Ratio | 1.015 |
| Operating PE Ratio | 11.51 |
| Normalized PE Ratio | 14.90 |